As per information provided by the Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health & Family Welfare, the Organization regulates safety, efficacy and quality of the drugs, medical devices and Cosmetics as per the provisions of Drugs and Cosmetics Act 1940 & Rules made thereunder. CDSCO and Ministry of Health & Family Welfare from time to time have taken various measures for ensuring the quality of drugs in the country, such as:

Drugs and Cosmetics Act, 1940 was amended in the year 2008 to provide stringent penalties for manufacturer of spurious and adulterated drugs and certain offences have also been made cognizable and non-bailable.

States/UTs were requested to set up Special Courts for trial of offences under the Drugs and Cosmetics Act for speedy disposal. So far, 33 states have already set up designated Special Courts.

Guidelines for taking action on samples of drugs declared as spurious or ‘not of standard quality’ in the light of enhanced penalties under the Drugs & Cosmetics (Amendment) Act, 2008 were forwarded to the State Drugs Controllers for uniform implementation.

Number of sanctioned posts in CDSCO have been increased from 111 in 2008 to 492 in January, 2021.

Testing capacities of Central Drugs Testing Laboratories under CDSCO are being constantly strengthened to expedite testing of drug samples in the country.

In order to ensure efficacy of drugs, the Drugs and Cosmetics Rules 1945 have been amended in April, 2017 providing that applicant shall submit the result of bioequivalence study along with the application for grant of manufacturing License of oral dosage form of drugs falling under the Category II and Category IV of the Biopharmaceutical Classification System.

Drugs and Cosmetics Rules 1945 have been amended in October, 2017 making it mandatory that before the grant of manufacturing license, the manufacturing establishment is to be the inspected jointly by Drugs Inspectors of the Central Government and the State Government concerned. Further, the licensed manufacturing premises are to be inspected jointly by the Drugs Inspectors of Central Government and State Government concerned to verify the compliance with the conditions of license and the provisions of the Drugs & Cosmetics Act and Rules for not less than once in three years or as needed as per risk based approach.

Drugs and Cosmetics Rules 1945 have been amended in April, 2018 making it mandatory that the applicants for all drugs shall submit evidence of stability, safety of excipients etc. to the State Licensing Authority before grant of product manufacturing license by the Authority.

Government has approved a proposal for strengthening the drug regulatory system in the country, both at the level of Central and the State Governments at a total expenditure of Rs. 1,750 crores.

The information was given by the Union Minister of Chemicals and Fertilizers, Shri Mansukh Mandaviya in a written reply in the Lok Sabha today.